drugset / Trial / NCT02144831
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
RandomizedParallel-groupDouble-blindPrevention
Summary
The primary goal of the research is to determine if 10 days of dual anti-platelet treatment is as effective as 30 days of similar treatment in the prevention of stroke, myocardial ischemia (MI) and death in patients with TIAs and minor stroke.
Timeline
- Start
- 2014-07
- Primary completion
- 2018-06
- Completion
- 2018-10
Outcome
Outcome not reported
Stopped: “Could not get study started”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 75 mg | Oral |
| Comparator | Aspirin | Small molecule | 75 mg | — |
| Comparator | Aspirin | Small molecule | 325 mg | — |